<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Cardiac causes of cyanosis in the newborn</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Cardiac causes of cyanosis in the newborn</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Cardiac causes of cyanosis in the newborn</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert L Geggel, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David R Fulton, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carrie Armsby, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 04, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>For neonates with cyanotic congenital heart disease (CHD), early recognition, emergency stabilization, and transport to a cardiac care center with expertise in the management of cyanotic CHD are important to ensure an optimal outcome.</p><p>The causes of cyanotic CHD in the newborn are presented here. The presentation and screening of critical CHD and initial management of infants with cyanotic CHD are reviewed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5774.html" rel="external">"Identifying newborns with critical congenital heart disease"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/101291.html" rel="external">"Newborn screening for critical congenital heart disease using pulse oximetry"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5785.html" rel="external">"Diagnosis and initial management of cyanotic heart disease in the newborn"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">DEFINITION OF CYANOSIS</span><span class="headingEndMark"> — </span>Cyanosis is a bluish discoloration of the tissues that results when the absolute level of reduced hemoglobin in the capillary bed exceeds 3 g/dL [<a href="#rid1">1-3</a>]. The appearance of cyanosis depends upon the total amount of reduced hemoglobin rather than the ratio of reduced-to-oxygenated hemoglobin.</p><p>Several factors can affect the detection of cyanosis:</p><p class="bulletIndent1"><span class="glyph">●</span>Hemoglobin concentration (cyanosis may not be apparent in patients with anemia)  (<a class="graphic graphic_figure graphicRef70325" href="/d/graphic/70325.html" rel="external">figure 1</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Skin pigmentation (cyanosis can be especially difficult to appreciate in infants with darkly pigmented skin)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Physiologic factors that affect the oxygen dissociation curve such as alkalosis, acidosis, cold temperature, low levels of 2,3-diphosphoglycerate, and high levels of fetal hemoglobin  (<a class="graphic graphic_figure graphicRef59739" href="/d/graphic/59739.html" rel="external">figure 2</a>)</p><p></p><p>A more detailed description of how these factors affect the detection of cyanosis is presented separately. (See  <a class="medical medical_review" href="/d/html/14305.html" rel="external">"Approach to cyanosis in the newborn"</a>.)</p><p>Routine pulse oximetry screening improves detection of cyanotic CHD, particularly in patients with mild desaturation. Newborn screening for critical CHD using pulse oximetry is discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/101291.html" rel="external">"Newborn screening for critical congenital heart disease using pulse oximetry"</a>.)</p><p class="headingAnchor" id="H3181369519"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Congenital heart disease (CHD) is the most common group of congenital disorders, with a reported prevalence ranging from 6 to 13 per 1000 live births [<a href="#rid4">4-9</a>]. Cyanotic cardiac lesions account for approximately 15 percent of all CHD cases [<a href="#rid4">4</a>] and one-third of potentially fatal forms of CHD (critical CHD)  (<a class="graphic graphic_table graphicRef103087" href="/d/graphic/103087.html" rel="external">table 1</a>) [<a href="#rid10">10,11</a>]. (See  <a class="medical medical_review" href="/d/html/5774.html" rel="external">"Identifying newborns with critical congenital heart disease", section on 'Epidemiology'</a>.)</p><p class="headingAnchor" id="H10"><span class="h1">NONCARDIAC CAUSES OF CYANOSIS</span><span class="headingEndMark"> — </span>Hypoxemia, with decreased arterial oxygen saturation leading to central cyanosis, can result from many different mechanisms  (<a class="graphic graphic_table graphicRef50161" href="/d/graphic/50161.html" rel="external">table 2</a>). (See  <a class="medical medical_review" href="/d/html/1647.html" rel="external">"Measures of oxygenation and mechanisms of hypoxemia", section on 'Mechanisms of hypoxemia'</a>.)</p><p>Common noncardiac causes of neonatal cyanosis include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pulmonary disorders</strong> – Pulmonary disorders are the most common causes of central cyanosis and include transient tachypnea of the newborn; respiratory distress syndrome; meconium aspiration; neonatal pneumonia; pneumothorax; hypoventilation; and structural abnormalities of the airway, lung, or diaphragm. (See  <a class="medical medical_review" href="/d/html/4964.html" rel="external">"Overview of neonatal respiratory distress and disorders of transition"</a> and  <a class="medical medical_review" href="/d/html/14305.html" rel="external">"Approach to cyanosis in the newborn", section on 'Pulmonary disorders'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Persistent pulmonary hypertension of the newborn (PPHN)</strong> – In PPHN, central cyanosis is caused by right-to-left shunting through the ductus arteriosus, resulting in differential cyanosis (ie, oxygen saturation measured in the arm [preductal] is higher than that in the leg [postductal]). (See  <a class="medical medical_review" href="/d/html/5045.html" rel="external">"Persistent pulmonary hypertension of the newborn (PPHN): Clinical features and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Poor peripheral perfusion/shock</strong> – Shock states are often characterized by poor peripheral perfusion and cyanosis. Noncardiac causes of neonatal shock include sepsis, hypovolemia, fetomaternal hemorrhage, and adrenal insufficiency  (<a class="graphic graphic_table graphicRef110373" href="/d/graphic/110373.html" rel="external">table 3</a>). (See  <a class="medical medical_review" href="/d/html/5039.html" rel="external">"Neonatal shock: Etiology, clinical manifestations, and evaluation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acrocyanosis</strong> – Acrocyanosis is often seen in healthy newborns and refers to the peripheral cyanosis around the mouth and extremities (hands and feet)  (<a class="graphic graphic_picture graphicRef108319" href="/d/graphic/108319.html" rel="external">picture 1</a>).</p><p></p><p>Noncardiac causes of cyanosis in newborns are discussed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/14305.html" rel="external">"Approach to cyanosis in the newborn", section on 'Causes of central cyanosis'</a>.)</p><p class="headingAnchor" id="H12"><span class="h1">CARDIAC CAUSES OF CYANOSIS</span><span class="headingEndMark"> — </span>A frequently used mnemonic to identify five of the more common cyanotic lesions is the "five T's" of cyanotic congenital heart disease (CHD):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>T</strong>ransposition of the great arteries, dextro type (D-TGA)  (<a class="graphic graphic_figure graphicRef68589" href="/d/graphic/68589.html" rel="external">figure 3</a>)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>T</strong>etralogy of Fallot (TOF)  (<a class="graphic graphic_figure graphicRef82493" href="/d/graphic/82493.html" rel="external">figure 4</a>)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>T</strong>runcus arteriosus  (<a class="graphic graphic_figure graphicRef83846" href="/d/graphic/83846.html" rel="external">figure 5</a>)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>T</strong>otal anomalous pulmonary venous connection (TAPVC)  (<a class="graphic graphic_figure graphicRef77375" href="/d/graphic/77375.html" rel="external">figure 6</a>)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>T</strong>ricuspid valve abnormalities  (<a class="graphic graphic_figure graphicRef79822" href="/d/graphic/79822.html" rel="external">figure 7</a> and <a class="graphic graphic_figure graphicRef88605" href="/d/graphic/88605.html" rel="external">figure 8</a>)</p><p></p><p>A sixth "T" is often added for "<strong>T</strong>ons of other lesions," such as double-outlet right ventricle, pulmonary atresia, multiple variations of single ventricle, hypoplastic left heart syndrome (HLHS), complex conditions associated with heterotaxy syndromes, or anomalous systemic venous connection (left superior vena cava connected to the left atrium).</p><p class="headingAnchor" id="H2825839179"><span class="h2">Overview of physiology</span><span class="headingEndMark"> — </span>In cyanotic CHD, central cyanosis results from right-to-left shunting. Cyanotic cardiac lesions can be categorized according to the underlying physiology as follows:</p><p class="bulletIndent1"><span class="glyph">●</span>Decreased pulmonary blood flow</p><p class="bulletIndent1"><span class="glyph">●</span>Increased pulmonary blood flow</p><p class="bulletIndent1"><span class="glyph">●</span>Severe heart failure</p><p></p><p>CHD lesions can also be categorized according to whether or not they are ductal-dependent. Ductal-dependent congenital heart lesions rely upon a patent ductus arteriosus (PDA)  (<a class="graphic graphic_figure graphicRef65828" href="/d/graphic/65828.html" rel="external">figure 9</a>) to supply pulmonary or systemic blood flow or to allow adequate mixing between parallel circulations. Many, but not all, cyanotic congenital heart defects are ductal-dependent  (<a class="graphic graphic_table graphicRef103087" href="/d/graphic/103087.html" rel="external">table 1</a>).</p><p>Congenital heart defects that are associated with right-to-left shunting across the PDA create differential cyanosis, in which the upper one-half of the body is pink and the lower one-half cyanotic. Differential cyanosis can occur in patients with severe coarctation of the aorta (CoA), interrupted aortic arch, or critical aortic stenosis. It may also occur in patients with structurally normal hearts who have persistent pulmonary hypertension of the newborn (PPHN). (See  <a class="medical medical_review" href="/d/html/5774.html" rel="external">"Identifying newborns with critical congenital heart disease", section on 'Differential cyanosis'</a>.)</p><p>Reversed differential cyanosis is a rare finding that may occur in patients with TGA associated with either coarctation or pulmonary hypertension. In these infants, oxygen saturation is higher in the lower than upper extremity. (See  <a class="medical medical_review" href="/d/html/14374.html" rel="external">"D-transposition of the great arteries (D-TGA): Anatomy, clinical features, and diagnosis"</a>.)</p><p class="headingAnchor" id="H13"><span class="h2">Decreased pulmonary blood flow</span><span class="headingEndMark"> — </span>Cyanotic lesions with decreased pulmonary blood flow include TOF, tricuspid valve anomalies, pulmonary valve atresia, and critical valvar pulmonary stenosis.</p><p class="headingAnchor" id="H14"><span class="h3">Tetralogy of Fallot</span><span class="headingEndMark"> — </span>TOF is a constellation of four anatomic defects, consisting of an overriding aorta, right ventricular hypertrophy, pulmonary stenosis, and ventricular septal defect  (<a class="graphic graphic_figure graphicRef82493" href="/d/graphic/82493.html" rel="external">figure 4</a> and <a class="graphic graphic_diagnosticimage graphicRef78997" href="/d/graphic/78997.html" rel="external">image 1</a>). The clinical presentation depends upon the degree of pulmonary stenosis. More severe stenosis leads to greater reduction of pulmonary blood flow and increased cyanosis. The clinical features, diagnosis, and management of TOF are discussed separately. (See  <a class="medical medical_review" href="/d/html/5769.html" rel="external">"Tetralogy of Fallot (TOF): Pathophysiology, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/5770.html" rel="external">"Tetralogy of Fallot (TOF): Management and outcome"</a>.)</p><p class="headingAnchor" id="H16"><span class="h3">Pulmonary atresia with intact ventricular septum</span><span class="headingEndMark"> — </span>Pulmonary atresia with intact ventricular septum (PA/IVS) is characterized by complete obstruction of right ventricular outflow with varying degrees of right ventricular and tricuspid valve hypoplasia  (<a class="graphic graphic_figure graphicRef101334" href="/d/graphic/101334.html" rel="external">figure 10</a>). Blood is thus unable to flow from the right ventricle to the pulmonary artery and lungs, and an alternative source of pulmonary blood flow (ie, a PDA) is required for survival. The clinical features, diagnosis, and management of PA/IVS are discussed separately. (See  <a class="medical medical_review" href="/d/html/87462.html" rel="external">"Pulmonary atresia with intact ventricular septum (PA/IVS)"</a>.)</p><p class="headingAnchor" id="H17"><span class="h3">Critical pulmonic stenosis</span><span class="headingEndMark"> — </span>Neonates with critical valvular pulmonic stenosis are also dependent on a PDA for adequate pulmonary perfusion. The clinical features, diagnosis, and management of critical pulmonic stenosis are discussed separately. (See  <a class="medical medical_review" href="/d/html/14578.html" rel="external">"Pulmonic stenosis in infants and children: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/114558.html" rel="external">"Pulmonic stenosis in infants and children: Management and outcome"</a>.)</p><p class="headingAnchor" id="H172998766"><span class="h3">Tricuspid valve anomalies</span><span class="headingEndMark"> — </span>Tricuspid valve anomalies include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Tricuspid atresia</strong> – In tricuspid atresia, there is no communication between the right atrium and right ventricle, which results in a total and obligatory right-to-left atrial shunt  (<a class="graphic graphic_figure graphicRef88605" href="/d/graphic/88605.html" rel="external">figure 8</a>). Other abnormalities may be present including ventricular septal defect, pulmonary stenosis, or TGA. The clinical features, diagnosis, and management of tricuspid atresia are discussed separately. (See  <a class="medical medical_review" href="/d/html/14587.html" rel="external">"Tricuspid valve atresia"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Tricuspid stenosis</strong> – Tricuspid stenosis is usually seen with hypoplastic right ventricle and atrial septal defect. This also results in an atrial-level right-to-left shunt.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ebstein anomaly</strong> – Ebstein anomaly is a malformation of the tricuspid valve  (<a class="graphic graphic_figure graphicRef79822" href="/d/graphic/79822.html" rel="external">figure 7</a>). The variation in clinical severity is related to the extent of the inferior displacement of the tricuspid leaflets from the tricuspid annulus. In the most serious form of this defect, the tricuspid valve is severely deformed, displaced into the right ventricular outflow tract, and becomes increasingly insufficient. As a result, the right ventricular cavity size is reduced and right ventricular outflow obstruction may result. Tricuspid regurgitation increases right atrial size and the diameter of a patent foramen ovale. Cyanosis results from right-to-left shunting at the atrial level but typically improves as pulmonary vascular resistance decreases in the neonatal transition period. The clinical features, diagnosis, and management of Ebstein anomaly are discussed separately. (See  <a class="medical medical_review" href="/d/html/8146.html" rel="external">"Ebstein anomaly: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/108790.html" rel="external">"Ebstein anomaly: Management and prognosis"</a>.)</p><p></p><p class="headingAnchor" id="H18"><span class="h2">Increased pulmonary blood flow</span><span class="headingEndMark"> — </span>Defects that present with cyanosis with increased pulmonary blood flow include D-TGA  (<a class="graphic graphic_figure graphicRef68589" href="/d/graphic/68589.html" rel="external">figure 3</a>), truncus arteriosus  (<a class="graphic graphic_figure graphicRef83846" href="/d/graphic/83846.html" rel="external">figure 5</a>), and TAPVC  (<a class="graphic graphic_figure graphicRef77375" href="/d/graphic/77375.html" rel="external">figure 6</a>).</p><p class="headingAnchor" id="H19"><span class="h3">D-transposition of the great arteries</span><span class="headingEndMark"> — </span>TGA is a ventriculo-arterial discordant lesion in which the aorta arises from the right ventricle and the pulmonary artery from the left ventricle  (<a class="graphic graphic_figure graphicRef68589" href="/d/graphic/68589.html" rel="external">figure 3</a>). The most common form of TGA is D-TGA, in which the origin of the aorta is anterior and rightward to the pulmonary artery origin. This creates two parallel circulations that result in cyanotic heart disease. The first sends deoxygenated systemic venous blood to the right atrium and back to the systemic circulation via the right ventricle and aorta, and the second sends oxygenated pulmonary venous blood to the left atrium and back to the pulmonary circulation via the left ventricle and pulmonary artery. In infants with D-TGA, survival depends upon mixing of these two circulations, which occurs at the level of the atria (patent foramen ovale), ventricles (approximately one-third of patients also have a ventricular septal defect), or great vessels (via the PDA). The clinical features, diagnosis, and management of D-TGA are discussed separately. (See  <a class="medical medical_review" href="/d/html/14374.html" rel="external">"D-transposition of the great arteries (D-TGA): Anatomy, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/15851.html" rel="external">"D-transposition of the great arteries (D-TGA): Management and outcome"</a>.)</p><p class="headingAnchor" id="H20"><span class="h3">Truncus arteriosus</span><span class="headingEndMark"> — </span>Truncus arteriosus is a condition in which a single great vessel arises from the heart  (<a class="graphic graphic_figure graphicRef83846" href="/d/graphic/83846.html" rel="external">figure 5</a>). The aorta, pulmonary arteries, and coronary arteries all originate from the ascending portion of this single vessel. There is always an associated ventricular septal defect. The single semilunar valve contains three to six cusps and may be regurgitant. The various subtypes of truncus arteriosus relate to the branching pattern of the pulmonary arteries. The aorta contains combined output from the left and right ventricles, resulting in cyanosis, which may be mild if pulmonary vascular resistance is low and pulmonary blood flow is excessive. In that case, cyanosis may not be visible. The clinical features, diagnosis, and management of truncus arteriosus are discussed separately. (See  <a class="medical medical_review" href="/d/html/14588.html" rel="external">"Truncus arteriosus"</a>.)</p><p class="headingAnchor" id="H21"><span class="h3">Total anomalous pulmonary venous connection</span><span class="headingEndMark"> — </span>TAPVC, also referred to as total anomalous pulmonary venous return (TAPVR), is a cyanotic congenital defect in which all four pulmonary veins fail to make their normal connection to the left atrium  (<a class="graphic graphic_figure graphicRef77375" href="/d/graphic/77375.html" rel="external">figure 6</a>). This results in drainage of all pulmonary venous return into the systematic venous circulation. The clinical manifestations, diagnosis, and management of TAPVC and its variants are discussed separately. (See  <a class="medical medical_review" href="/d/html/5767.html" rel="external">"Total anomalous pulmonary venous connection"</a>.)</p><p class="headingAnchor" id="H22"><span class="h2">Left-sided obstructive lesions</span><span class="headingEndMark"> — </span>Severe left-sided obstructive lesions can present in the newborn period with heart failure or cardiogenic shock accompanied by cyanosis. Left-sided obstructive lesions include HLHS  (<a class="graphic graphic_figure graphicRef82280" href="/d/graphic/82280.html" rel="external">figure 11</a>), severe CoA  (<a class="graphic graphic_figure graphicRef103747" href="/d/graphic/103747.html" rel="external">figure 12</a>), interrupted aortic arch  (<a class="graphic graphic_figure graphicRef103748" href="/d/graphic/103748.html" rel="external">figure 13</a>), and critical valvular aortic stenosis. These lesions depend upon a PDA to supply systemic blood flow. As the ductus closes, cyanosis, pulmonary edema, metabolic acidosis, and hypotension develop (cardiogenic shock).</p><p class="headingAnchor" id="H23"><span class="h3">Hypoplastic left heart syndrome</span><span class="headingEndMark"> — </span>HLHS consists of a number of defects involving underdevelopment of the left-sided chambers and valves  (<a class="graphic graphic_figure graphicRef82280" href="/d/graphic/82280.html" rel="external">figure 11</a>). Most commonly, there is aortic valve atresia, severe mitral valve stenosis, and marked hypoplasia of the left ventricle. In HLHS, right-to-left shunting via the PDA provides retrograde perfusion of the ascending and transverse portions of the aorta, so that the subclavian, carotid, and coronary arteries are supplied. If untreated, HLHS is almost always fatal within the first few weeks of life. With modern medical therapy and surgical interventions, approximately 60 to 70 of affected infants survive past the age of five years. However, there is considerable morbidity. The clinical features, diagnosis, and management of HLHS are discussed separately. (See  <a class="medical medical_review" href="/d/html/14370.html" rel="external">"Hypoplastic left heart syndrome: Anatomy, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/116293.html" rel="external">"Hypoplastic left heart syndrome: Management and outcome"</a>.)</p><p class="headingAnchor" id="H24"><span class="h3">Coarctation of the aorta</span><span class="headingEndMark"> — </span>CoA is a discrete narrowing of the aorta, which typically involves a thoracic preductal location distal to the left subclavian artery  (<a class="graphic graphic_figure graphicRef103747" href="/d/graphic/103747.html" rel="external">figure 12</a>). Infants with a severe CoA may present with heart failure when the ductus arteriosus closes. The clinical manifestations, diagnosis, and management of CoA are discussed separately. (See  <a class="medical medical_review" href="/d/html/5760.html" rel="external">"Clinical manifestations and diagnosis of coarctation of the aorta"</a> and  <a class="medical medical_review" href="/d/html/5784.html" rel="external">"Management of coarctation of the aorta"</a>.)</p><p class="headingAnchor" id="H25"><span class="h3">Interrupted aortic arch</span><span class="headingEndMark"> — </span>The most extreme form of coarctation is an interrupted aortic arch  (<a class="graphic graphic_figure graphicRef103748" href="/d/graphic/103748.html" rel="external">figure 13</a>). Complete interruption usually occurs between the left common carotid and left subclavian arteries, but can occur distal to the left subclavian artery or between the innominate artery and left common carotid artery, and is usually associated with a large, nonrestrictive ventricular septal defect. Surgical correction is required for both the arch obstruction and the ventricular septal defect.</p><p class="headingAnchor" id="H26"><span class="h3">Critical aortic stenosis</span><span class="headingEndMark"> — </span>Severe left ventricular outflow tract obstruction due to critical valvular aortic stenosis results in cyanosis and heart failure or even cardiogenic shock. Affected infants may not have an appreciable ejection murmur and may have minimal gradient across the valve as measured by Doppler echocardiography because of severe LV dysfunction and poor cardiac output. The clinical features, diagnosis, and management of aortic stenosis are discussed separately. (See  <a class="medical medical_review" href="/d/html/5775.html" rel="external">"Valvar aortic stenosis in children"</a> and  <a class="medical medical_review" href="/d/html/5776.html" rel="external">"Subvalvar aortic stenosis (subaortic stenosis)"</a>.)</p><p class="headingAnchor" id="H257415087"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/115414.html" rel="external">"Society guideline links: Congenital heart disease in infants and children"</a>.)</p><p class="headingAnchor" id="H27911242"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword[s] of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/83995.html" rel="external">"Patient education: Tetralogy of Fallot (The Basics)"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/83037.html" rel="external">"Patient education: Aortic coarctation in children (The Basics)"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/85377.html" rel="external">"Patient education: Total anomalous pulmonary venous connection in children (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H172999188"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>In cyanotic congenital heart disease (CHD), central cyanosis results from right-to-left shunting. Several factors can affect the detection of cyanosis, including hemoglobin concentration  (<a class="graphic graphic_figure graphicRef70325" href="/d/graphic/70325.html" rel="external">figure 1</a>), skin pigmentation, and physiologic factors that affect the oxygen dissociation curve. Routine pulse oximetry screening improves detection of cyanotic CHD, particularly in patients with mild desaturation. (See <a class="local">'Definition of cyanosis'</a> above and  <a class="medical medical_review" href="/d/html/101291.html" rel="external">"Newborn screening for critical congenital heart disease using pulse oximetry"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cyanotic cardiac lesions account for approximately 15 percent of all CHD and one-third of potentially fatal cases of CHD (ie, critical CHD  (<a class="graphic graphic_table graphicRef103087" href="/d/graphic/103087.html" rel="external">table 1</a>)). (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ductal-dependent congenital heart lesions are dependent upon a patent ductus arteriosus (PDA)  (<a class="graphic graphic_figure graphicRef65828" href="/d/graphic/65828.html" rel="external">figure 9</a>) to supply pulmonary or systemic blood flow or to allow adequate mixing between parallel circulations. Many, but not all, cyanotic congenital heart defects are ductal-dependent  (<a class="graphic graphic_table graphicRef103087" href="/d/graphic/103087.html" rel="external">table 1</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cyanotic CHD lesions can be classified based on their physiology as follows:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Decreased pulmonary blood flow – Tetralogy of Fallot  (<a class="graphic graphic_figure graphicRef82493" href="/d/graphic/82493.html" rel="external">figure 4</a>), pulmonary atresia with intact ventricular septum (PA/IVS)  (<a class="graphic graphic_figure graphicRef101334" href="/d/graphic/101334.html" rel="external">figure 10</a>), critical valvar pulmonic stenosis, and tricuspid valve anomalies  (<a class="graphic graphic_figure graphicRef88605" href="/d/graphic/88605.html" rel="external">figure 8</a> and <a class="graphic graphic_figure graphicRef79822" href="/d/graphic/79822.html" rel="external">figure 7</a>). (See <a class="local">'Decreased pulmonary blood flow'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Increased pulmonary blood flow – Transposition of the great arteries  (<a class="graphic graphic_figure graphicRef68589" href="/d/graphic/68589.html" rel="external">figure 3</a>), truncus arteriosus  (<a class="graphic graphic_figure graphicRef83846" href="/d/graphic/83846.html" rel="external">figure 5</a>), and total anomalous pulmonary venous connection  (<a class="graphic graphic_figure graphicRef77375" href="/d/graphic/77375.html" rel="external">figure 6</a>). (See <a class="local">'Increased pulmonary blood flow'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Left-sided obstructive lesions – As the ductus arteriosus closes, severe obstructive left-sided heart lesions may present with heart failure or cardiogenic shock, accompanied by cyanosis. These lesions include hypoplastic left heart syndrome (HLHS)  (<a class="graphic graphic_figure graphicRef82280" href="/d/graphic/82280.html" rel="external">figure 11</a>), coarctation of the aorta (CoA)  (<a class="graphic graphic_figure graphicRef103747" href="/d/graphic/103747.html" rel="external">figure 12</a>), interrupted aortic arch  (<a class="graphic graphic_figure graphicRef103748" href="/d/graphic/103748.html" rel="external">figure 13</a>), and critical aortic stenosis. (See <a class="local">'Left-sided obstructive lesions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A frequently used mnemonic to identify five of the more common cyanotic diseases is the "five T's" of cyanotic CHD (see <a class="local">'Cardiac causes of cyanosis'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>T</strong>ransposition of the great arteries (TGA)  (<a class="graphic graphic_figure graphicRef68589" href="/d/graphic/68589.html" rel="external">figure 3</a>)</p><p class="bulletIndent2"><span class="glyph">•</span><strong>T</strong>etralogy of Fallot (TOF)  (<a class="graphic graphic_figure graphicRef82493" href="/d/graphic/82493.html" rel="external">figure 4</a>)</p><p class="bulletIndent2"><span class="glyph">•</span><strong>T</strong>runcus arteriosus  (<a class="graphic graphic_figure graphicRef83846" href="/d/graphic/83846.html" rel="external">figure 5</a>)</p><p class="bulletIndent2"><span class="glyph">•</span><strong>T</strong>otal anomalous pulmonary venous connection (TAPVC)  (<a class="graphic graphic_figure graphicRef77375" href="/d/graphic/77375.html" rel="external">figure 6</a>)</p><p class="bulletIndent2"><span class="glyph">•</span><strong>T</strong>ricuspid valve abnormalities  (<a class="graphic graphic_figure graphicRef88605" href="/d/graphic/88605.html" rel="external">figure 8</a> and <a class="graphic graphic_figure graphicRef79822" href="/d/graphic/79822.html" rel="external">figure 7</a>)</p><p></p><p class="bulletIndent1">A sixth "T" is often added for "<strong>T</strong>ons of other lesions" (eg, double-outlet right ventricle, pulmonary atresia, HLHS and other variants of single ventricle, heterotaxy, anomalous systemic venous connection).</p><p></p><p class="headingAnchor" id="H204503014"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The editorial staff at UpToDate acknowledge Laurie B Armsby, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Lees MH. Cyanosis of the newborn infant. Recognition and clinical evaluation. J Pediatr 1970; 77:484.</a></li><li><a class="nounderline abstract_t">Marino BS, Bird GL, Wernovsky G. Diagnosis and management of the newborn with suspected congenital heart disease. Clin Perinatol 2001; 28:91.</a></li><li class="breakAll">Nadas AS, Fyler DC. Hypoxemia. In: Nadas' Pediatric Cardiology, 2nd ed, Keane JF, Lock JE, and Fyler DC (Eds), Saunders Elsevier, Philadelphia 2006. p.97.</li><li><a class="nounderline abstract_t">Reller MD, Strickland MJ, Riehle-Colarusso T, et al. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr 2008; 153:807.</a></li><li><a class="nounderline abstract_t">Khoshnood B, Lelong N, Houyel L, et al. Prevalence, timing of diagnosis and mortality of newborns with congenital heart defects: a population-based study. Heart 2012; 98:1667.</a></li><li><a class="nounderline abstract_t">Ishikawa T, Iwashima S, Ohishi A, et al. Prevalence of congenital heart disease assessed by echocardiography in 2067 consecutive newborns. Acta Paediatr 2011; 100:e55.</a></li><li><a class="nounderline abstract_t">Wren C, Irving CA, Griffiths JA, et al. Mortality in infants with cardiovascular malformations. Eur J Pediatr 2012; 171:281.</a></li><li><a class="nounderline abstract_t">Liu S, Joseph KS, Lisonkova S, et al. Association between maternal chronic conditions and congenital heart defects: a population-based cohort study. Circulation 2013; 128:583.</a></li><li><a class="nounderline abstract_t">Ferencz C, Rubin JD, McCarter RJ, et al. Congenital heart disease: prevalence at livebirth. The Baltimore-Washington Infant Study. Am J Epidemiol 1985; 121:31.</a></li><li><a class="nounderline abstract_t">Wren C, Reinhardt Z, Khawaja K. Twenty-year trends in diagnosis of life-threatening neonatal cardiovascular malformations. Arch Dis Child Fetal Neonatal Ed 2008; 93:F33.</a></li><li><a class="nounderline abstract_t">Talner CN. Report of the New England Regional Infant Cardiac Program, by Donald C. Fyler, MD, Pediatrics, 1980;65(suppl):375-461. Pediatrics 1998; 102:258.</a></li></ol></div><div id="topicVersionRevision">Topic 5780 Version 32.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5502102" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Cyanosis of the newborn infant. Recognition and clinical evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11265513" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Diagnosis and management of the newborn with suspected congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11265513" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Diagnosis and management of the newborn with suspected congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18657826" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22888161" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Prevalence, timing of diagnosis and mortality of newborns with congenital heart defects: a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21362039" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Prevalence of congenital heart disease assessed by echocardiography in 2067 consecutive newborns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21748291" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Mortality in infants with cardiovascular malformations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23812182" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Association between maternal chronic conditions and congenital heart defects: a population-based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3964990" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Congenital heart disease: prevalence at livebirth. The Baltimore-Washington Infant Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17556383" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Twenty-year trends in diagnosis of life-threatening neonatal cardiovascular malformations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9651450" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Report of the New England Regional Infant Cardiac Program, by Donald C. Fyler, MD, Pediatrics, 1980;65(suppl):375-461.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
